Trinity Biotech (TRIB) Institutional Ownership $0.92 +0.03 (+2.90%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$0.93 +0.02 (+1.79%) As of 08/8/2025 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Trinity Biotech (NASDAQ:TRIB)CurrentInstitutional OwnershipPercentage78.97%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$86.06KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$53.78K Get TRIB Insider Trade Alerts Want to know when executives and insiders are buying or selling Trinity Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TRIB Institutional Buying and Selling by Quarter Trinity Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/5/2025 Hunter Associates Investment Management LLC437,910$284K0.0%+16.7%2.426% 2/13/2025Renaissance Technologies LLC189,053$166K0.0%-24.4%1.047% 1/23/2025 Hunter Associates Investment Management LLC378,590$334K0.1%+5.2%0.000% 10/24/2024 Hunter Associates Investment Management LLC359,810$390K0.1%+7.8%4.722% 8/6/2024 Acadian Asset Management LLC72,110$149K0.0%-38.0%0.946% 5/17/2024Whitefort Capital Management LP81,902$167K0.1%-80.0%1.075% 5/10/2024 Acadian Asset Management LLC116,276$237K0.0%-83.0%1.526% 5/2/2024 Hunter Associates Investment Management LLC317,810$644K0.1%-80.5%4.171% 1/31/2024 Hunter Associates Investment Management LLC1,625,900$700K0.1%-6.1%4.266% 8/15/2023Stonehill Capital Management LLC1,512,975$1.44M0.9%-4.7%3.970% Get the Latest News and Ratings for TRIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. 8/7/2023 Acadian Asset Management LLC727,954$701K0.0%-2.0%1.910% 8/3/2023 Hunter Associates Investment Management LLC1,724,000$1.66M0.3%-2.9%4.524% 7/13/2023 Cambridge Investment Research Advisors Inc.111,400$106K0.0%N/A0.292% 5/12/2023Aristides Capital LLC162,317$153K0.1%-26.1%0.426% 5/2/2023 Hunter Associates Investment Management LLC1,775,100$1.68M0.4%-2.7%4.658% 2/1/2023 Hunter Associates Investment Management LLC1,823,633$1.81M0.4%+1.5%4.785% 11/2/2022 Hunter Associates Investment Management LLC1,797,190$1.91M0.5%-0.6%4.716% 8/10/2022 Hunter Associates Investment Management LLC1,808,533$2.20M0.5%-25.0%6.719% 5/12/2022 Acadian Asset Management LLC815,461$862K0.0%-3.3%3.901% 5/11/2022Highbridge Capital Management LLC1,151,610$1.22M0.0%N/A5.510% 4/26/2022 Hunter Associates Investment Management LLC2,412,116$2.56M0.8%+5.5%11.540% 2/14/2022Stonehill Capital Management LLC219,946$315K0.1%-55.0%1.052% 2/14/2022Whitefort Capital Management LP35,068$50K0.0%N/A0.168% 2/10/2022 Acadian Asset Management LLC843,523$1.20M0.0%-1.4%4.036% 2/4/2022 Envestnet Asset Management Inc.110,901$159K0.0%N/A0.531% 1/27/2022 Hunter Associates Investment Management LLC2,286,150$3.27M0.9%+9.1%10.937% 11/18/2021Wealthsource Partners LLC30,200$65K0.0%N/A0.144% 11/15/2021Marshall Wace LLP34,703$75K0.0%-37.5%0.166% 11/15/2021 Hunter Associates Investment Management LLC2,095,900$4.53M1.5%+2.0%10.027% 11/12/2021Renaissance Technologies LLC1,746,841$3.77M0.0%-5.6%8.357% 10/28/2021 Navellier & Associates Inc.15,485$33K0.0%-84.6%0.074% 8/25/2021Marshall Wace LLP55,557$163K0.0%-38.7%0.266% 8/16/2021Marshall Wace LLP55,557$163K0.0%-38.7%0.266% 8/13/2021Renaissance Technologies LLC1,850,082$5.44M0.0%+0.3%8.851% 8/13/2021LPL Financial LLC60,073$177K0.0%+171.5%0.287% 8/9/2021 Navellier & Associates Inc100,611$296K0.0%+23.1%0.481% 5/19/2021Squarepoint Ops LLC36,450$137K0.0%N/A0.174% 5/18/2021Millennium Management LLC59,019$222K0.0%-39.5%0.282% (Data available from 1/1/2016 forward) TRIB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TRIB shares? During the previous two years, the following institutional investors and hedge funds held shares of Trinity Biotech shares: Stonehill Capital Management LLC ($1.44M), Hunter Associates Investment Management LLC ($284K), Whitefort Capital Management LP ($167K), and Renaissance Technologies LLC ($166K), Acadian Asset Management LLC ($149K).Learn more on Trinity Biotech's institutional investors. What percentage of Trinity Biotech's stock is owned by institutional investors? 78.97% of Trinity Biotech's stock is owned by institutional investors. Learn more on TRIB's institutional investor holdings. Which institutional investors have been buying Trinity Biotech's stock? The following institutional investors have purchased Trinity Biotech's stock in the last 24 months: Hunter Associates Investment Management LLC ($107.68K). How much institutional buying is happening at Trinity Biotech? Institutional investors have bought a total of 107,680 shares in the last 24 months. This purchase volume represents approximately $86.06K in transactions. Which of Trinity Biotech's major shareholders have been selling company stock? The following institutional investors have sold Trinity Biotech stock in the last 24 months: Renaissance Technologies LLC ($61.10K). How much institutional selling is happening at Trinity Biotech? Institutional investors have sold a total of 61,100 shares in the last 24 months. This volume of shares sold represents approximately $53.78K in transactions. Related Companies PDS Biotechnology Institutional Ownership CEL-SCI Institutional Ownership Annovis Bio Institutional Ownership OS Therapies Institutional Ownership Adverum Biotechnologies Institutional Ownership KALA BIO Institutional Ownership Prelude Therapeutics Institutional Ownership ABVC BioPharma Institutional Ownership vTv Therapeutics Institutional Ownership Century Therapeutics Institutional Ownership This page (NASDAQ:TRIB) was last updated on 8/10/2025 by MarketBeat.com Staff From Our Partners#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trinity Biotech PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Trinity Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
